期刊
NATURE REVIEWS DRUG DISCOVERY
卷 13, 期 10, 页码 741-758出版社
NATURE PORTFOLIO
DOI: 10.1038/nrd4368
关键词
-
资金
- US Defense Advanced Research Projects Agency (DARPA) [W911NF-13-1-0070]
- Shriners Hospital for Crippled Children [87200]
Sepsis, a common and potentially fatal systemic illness, is triggered by microbial infection and often leads to impaired function of the lungs, kidneys or other vital organs. Since the early 1980s, a large number of therapeutic agents for the treatment of sepsis have been evaluated in randomized controlled clinical trials. With few exceptions, the results from these trials have been disappointing, and no specific therapeutic agent is currently approved for the treatment of sepsis. To improve upon this dismal record, investigators will need to identify more suitable therapeutic targets, improve their approaches for selecting candidate compounds for clinical development and adopt better designs for clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据